Remove Family Practice Remove Hospital Remove Internal Medicine Remove Medical
article thumbnail

DASH Diet for Diabetes With Low Sodium Reduces BP in Those With Diabetes

Physician's Weekly

WEDNESDAY, June 18, 2025 (HealthDay News) — The Dietary Approaches to Stop Hypertension for Diabetes (DASH4D) diet with lower sodium is tied to clinically meaningful blood pressure reduction in people with diabetes, according to a study published online June 9 in JAMA Internal Medicine. Pilla, M.D.,

article thumbnail

Incidence Rates of Appendiceal Adenocarcinoma Increasing

Physician's Weekly

MONDAY, June 16, 2025 (HealthDay News) — The incidence rates of appendiceal adenocarcinoma (AA) increased after 1945, according to a study published online June 10 in the Annals of Internal Medicine. Andreana N. Holowatyj, Ph.D.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

‘Gas Station Heroin’ Spurs Spike in Poison Control Calls, FDA Warns

Physician's Weekly

But the FDA has never approved it for any medical condition in the U.S. Calello explained that it falls under a gray area of consumer supplements or products that are not regulated or tested the same way a medication would be. Tianeptine is sold in a number of countries as a government-approved treatment for depression.

Medical 52
article thumbnail

FDA Approves Polypill Widaplik for Hypertension

Physician's Weekly

The combination pill is the first and only FDA-approved triple combination medication for use as an initial therapy in patients who will likely need multiple drugs to achieve their ideal blood pressure numbers. The pill is available in a standard dose, as well as two low doses, and can be used in those initiating treatment.

article thumbnail

Insurers Promise to Speed Up Delays in Health Care Approvals

Physician's Weekly

It’s “going to streamline it in some incremental ways only,” Dr. Adam Gaffney , a critical care doctor and assistant professor at Harvard Medical School, told NBC News. Medical professionals will be required to review all denials (though insurers say they already do this). But experts say the changes may not go far enough.

article thumbnail

CT Colonography Cost-Effective, Clinically Effective for CRC Screening

Physician's Weekly

Several authors disclosed ties to the biotechnology and medical technology industries, including Bracco Diagnostics, which partially funded the study. Abstract/Full Text Editorial (subscription or payment may be required) Copyright © 2025 HealthDay.

article thumbnail

ADA: Orforglipron Reduces Glycated Hemoglobin in Early Type 2 Diabetes

Physician's Weekly

from the Velocity Clinical Research Center at Medical City Dallas, and colleagues conducted a phase 3 trial involving participants with type 2 diabetes treated only with diet and exercise, an HbA1c level of ≥7.0 Julio Rosenstock, M.D., percent, and a body mass index of at least 23.0